TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Drugs for Herpes Labialis Oral Herpes 1.2 Key Market Segments 1.2.1 Drugs for Herpes Labialis Oral Herpes Segment by Type 1.2.2 Drugs for Herpes Labialis Oral Herpes Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Drugs for Herpes Labialis Oral Herpes Market Overview 2.1 Global Market Overview 2.1.1 Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Drugs for Herpes Labialis Oral Herpes Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Drugs for Herpes Labialis Oral Herpes Market Competitive Landscape 3.1 Global Drugs for Herpes Labialis Oral Herpes Sales by Manufacturers (2017-2022) 3.2 Global Drugs for Herpes Labialis Oral Herpes Revenue Market Share by Manufacturers (2017-2022) 3.3 Drugs for Herpes Labialis Oral Herpes Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Drugs for Herpes Labialis Oral Herpes Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Drugs for Herpes Labialis Oral Herpes Sales Sites, Area Served, Product Type 3.6 Drugs for Herpes Labialis Oral Herpes Market Competitive Situation and Trends 3.6.1 Drugs for Herpes Labialis Oral Herpes Market Concentration Rate 3.6.2 Global 5 and 10 Largest Drugs for Herpes Labialis Oral Herpes Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Drugs for Herpes Labialis Oral Herpes Industry Chain Analysis 4.1 Drugs for Herpes Labialis Oral Herpes Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Drugs for Herpes Labialis Oral Herpes Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Drugs for Herpes Labialis Oral Herpes Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Type (2017-2022) 6.3 Global Drugs for Herpes Labialis Oral Herpes Market Size Market Share by Type (2017-2022) 6.4 Global Drugs for Herpes Labialis Oral Herpes Price by Type (2017-2022) 7 Drugs for Herpes Labialis Oral Herpes Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Drugs for Herpes Labialis Oral Herpes Market Sales by Application (2017-2022) 7.3 Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD) by Application (2017-2022) 7.4 Global Drugs for Herpes Labialis Oral Herpes Sales Growth Rate by Application (2017-2022) 8 Drugs for Herpes Labialis Oral Herpes Market Segmentation by Region 8.1 Global Drugs for Herpes Labialis Oral Herpes Sales by Region 8.1.1 Global Drugs for Herpes Labialis Oral Herpes Sales by Region 8.1.2 Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Region 8.2 North America 8.2.1 North America Drugs for Herpes Labialis Oral Herpes Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Drugs for Herpes Labialis Oral Herpes Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Drugs for Herpes Labialis Oral Herpes Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Drugs for Herpes Labialis Oral Herpes Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Drugs for Herpes Labialis Oral Herpes Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 GSK 9.1.1 GSK Drugs for Herpes Labialis Oral Herpes Basic Information 9.1.2 GSK Drugs for Herpes Labialis Oral Herpes Product Overview 9.1.3 GSK Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.1.4 GSK Business Overview 9.1.5 GSK Drugs for Herpes Labialis Oral Herpes SWOT Analysis 9.1.6 GSK Recent Developments 9.2 Novartis 9.2.1 Novartis Drugs for Herpes Labialis Oral Herpes Basic Information 9.2.2 Novartis Drugs for Herpes Labialis Oral Herpes Product Overview 9.2.3 Novartis Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.2.4 Novartis Business Overview 9.2.5 Novartis Drugs for Herpes Labialis Oral Herpes SWOT Analysis 9.2.6 Novartis Recent Developments 9.3 Teva 9.3.1 Teva Drugs for Herpes Labialis Oral Herpes Basic Information 9.3.2 Teva Drugs for Herpes Labialis Oral Herpes Product Overview 9.3.3 Teva Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.3.4 Teva Business Overview 9.3.5 Teva Drugs for Herpes Labialis Oral Herpes SWOT Analysis 9.3.6 Teva Recent Developments 9.4 Mylan 9.4.1 Mylan Drugs for Herpes Labialis Oral Herpes Basic Information 9.4.2 Mylan Drugs for Herpes Labialis Oral Herpes Product Overview 9.4.3 Mylan Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.4.4 Mylan Business Overview 9.4.5 Mylan Drugs for Herpes Labialis Oral Herpes SWOT Analysis 9.4.6 Mylan Recent Developments 9.5 Cadila 9.5.1 Cadila Drugs for Herpes Labialis Oral Herpes Basic Information 9.5.2 Cadila Drugs for Herpes Labialis Oral Herpes Product Overview 9.5.3 Cadila Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.5.4 Cadila Business Overview 9.5.5 Cadila Drugs for Herpes Labialis Oral Herpes SWOT Analysis 9.5.6 Cadila Recent Developments 9.6 Apotex 9.6.1 Apotex Drugs for Herpes Labialis Oral Herpes Basic Information 9.6.2 Apotex Drugs for Herpes Labialis Oral Herpes Product Overview 9.6.3 Apotex Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.6.4 Apotex Business Overview 9.6.5 Apotex Recent Developments 9.7 Daewoong Pharmaceutical 9.7.1 Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Basic Information 9.7.2 Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Product Overview 9.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.7.4 Daewoong Pharmaceutical Business Overview 9.7.5 Daewoong Pharmaceutical Recent Developments 9.8 Livzon 9.8.1 Livzon Drugs for Herpes Labialis Oral Herpes Basic Information 9.8.2 Livzon Drugs for Herpes Labialis Oral Herpes Product Overview 9.8.3 Livzon Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.8.4 Livzon Business Overview 9.8.5 Livzon Recent Developments 9.9 Luoxin 9.9.1 Luoxin Drugs for Herpes Labialis Oral Herpes Basic Information 9.9.2 Luoxin Drugs for Herpes Labialis Oral Herpes Product Overview 9.9.3 Luoxin Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.9.4 Luoxin Business Overview 9.9.5 Luoxin Recent Developments 9.10 Med shine 9.10.1 Med shine Drugs for Herpes Labialis Oral Herpes Basic Information 9.10.2 Med shine Drugs for Herpes Labialis Oral Herpes Product Overview 9.10.3 Med shine Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.10.4 Med shine Business Overview 9.10.5 Med shine Recent Developments 9.11 Bayer (Campho Phenique) 9.11.1 Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Basic Information 9.11.2 Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Product Overview 9.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.11.4 Bayer (Campho Phenique) Business Overview 9.11.5 Bayer (Campho Phenique) Recent Developments 9.12 Blistex 9.12.1 Blistex Drugs for Herpes Labialis Oral Herpes Basic Information 9.12.2 Blistex Drugs for Herpes Labialis Oral Herpes Product Overview 9.12.3 Blistex Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.12.4 Blistex Business Overview 9.12.5 Blistex Recent Developments 9.13 Kelun 9.13.1 Kelun Drugs for Herpes Labialis Oral Herpes Basic Information 9.13.2 Kelun Drugs for Herpes Labialis Oral Herpes Product Overview 9.13.3 Kelun Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.13.4 Kelun Business Overview 9.13.5 Kelun Recent Developments 9.14 Hikma 9.14.1 Hikma Drugs for Herpes Labialis Oral Herpes Basic Information 9.14.2 Hikma Drugs for Herpes Labialis Oral Herpes Product Overview 9.14.3 Hikma Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.14.4 Hikma Business Overview 9.14.5 Hikma Recent Developments 9.15 Haiwang 9.15.1 Haiwang Drugs for Herpes Labialis Oral Herpes Basic Information 9.15.2 Haiwang Drugs for Herpes Labialis Oral Herpes Product Overview 9.15.3 Haiwang Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.15.4 Haiwang Business Overview 9.15.5 Haiwang Recent Developments 9.16 Carmex 9.16.1 Carmex Drugs for Herpes Labialis Oral Herpes Basic Information 9.16.2 Carmex Drugs for Herpes Labialis Oral Herpes Product Overview 9.16.3 Carmex Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.16.4 Carmex Business Overview 9.16.5 Carmex Recent Developments 9.17 Cipher 9.17.1 Cipher Drugs for Herpes Labialis Oral Herpes Basic Information 9.17.2 Cipher Drugs for Herpes Labialis Oral Herpes Product Overview 9.17.3 Cipher Drugs for Herpes Labialis Oral Herpes Product Market Performance 9.17.4 Cipher Business Overview 9.17.5 Cipher Recent Developments 10 Drugs for Herpes Labialis Oral Herpes Market Forecast by Region 10.1 Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast 10.2 Global Drugs for Herpes Labialis Oral Herpes Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country 10.2.3 Asia Pacific Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Region 10.2.4 South America Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Drugs for Herpes Labialis Oral Herpes by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Drugs for Herpes Labialis Oral Herpes Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Drugs for Herpes Labialis Oral Herpes by Type (2022-2028) 11.1.2 Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Drugs for Herpes Labialis Oral Herpes by Type (2022-2028) 11.2 Global Drugs for Herpes Labialis Oral Herpes Market Forecast by Application (2022-2028) 11.2.1 Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) Forecast by Application 11.2.2 Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Drugs for Herpes Labialis Oral Herpes Market Size (M USD) Comparison by Region (M USD) Table 5. Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Manufacturers (2017-2022) Table 7. Global Drugs for Herpes Labialis Oral Herpes Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Drugs for Herpes Labialis Oral Herpes Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis Oral Herpes as of 2021) Table 10. Global Market Drugs for Herpes Labialis Oral Herpes Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Drugs for Herpes Labialis Oral Herpes Sales Sites and Area Served Table 12. Manufacturers Drugs for Herpes Labialis Oral Herpes Product Type Table 13. Global Drugs for Herpes Labialis Oral Herpes Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Drugs for Herpes Labialis Oral Herpes Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Drugs for Herpes Labialis Oral Herpes Market Challenges Table 22. Market Restraints Table 23. Global Drugs for Herpes Labialis Oral Herpes Sales by Type (K Units) Table 24. Global Drugs for Herpes Labialis Oral Herpes Market Size by Type (M USD) Table 25. Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) by Type (2017-2022) Table 26. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Type (2017-2022) Table 27. Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD) by Type (2017-2022) Table 28. Global Drugs for Herpes Labialis Oral Herpes Market Size Share by Type (2017-2022) Table 29. Global Drugs for Herpes Labialis Oral Herpes Price (USD/Unit) by Type (2017-2022) Table 30. Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) by Application Table 31. Global Drugs for Herpes Labialis Oral Herpes Market Size by Application Table 32. Global Drugs for Herpes Labialis Oral Herpes Sales by Application (2017-2022) & (K Units) Table 33. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Application (2017-2022) Table 34. Global Drugs for Herpes Labialis Oral Herpes Sales by Application (2017-2022) & (M USD) Table 35. Global Drugs for Herpes Labialis Oral Herpes Market Share by Application (2017-2022) Table 36. Global Drugs for Herpes Labialis Oral Herpes Sales Growth Rate by Application (2017-2022) Table 37. Global Drugs for Herpes Labialis Oral Herpes Sales by Region (2017-2022) & (K Units) Table 38. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Region (2017-2022) Table 39. North America Drugs for Herpes Labialis Oral Herpes Sales by Country (2017-2022) & (K Units) Table 40. Europe Drugs for Herpes Labialis Oral Herpes Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Drugs for Herpes Labialis Oral Herpes Sales by Region (2017-2022) & (K Units) Table 42. South America Drugs for Herpes Labialis Oral Herpes Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Drugs for Herpes Labialis Oral Herpes Sales by Region (2017-2022) & (K Units) Table 44. GSK Drugs for Herpes Labialis Oral Herpes Basic Information Table 45. GSK Drugs for Herpes Labialis Oral Herpes Product Overview Table 46. GSK Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. GSK Business Overview Table 48. GSK Drugs for Herpes Labialis Oral Herpes SWOT Analysis Table 49. GSK Recent Developments Table 50. Novartis Drugs for Herpes Labialis Oral Herpes Basic Information Table 51. Novartis Drugs for Herpes Labialis Oral Herpes Product Overview Table 52. Novartis Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Novartis Business Overview Table 54. Novartis Drugs for Herpes Labialis Oral Herpes SWOT Analysis Table 55. Novartis Recent Developments Table 56. Teva Drugs for Herpes Labialis Oral Herpes Basic Information Table 57. Teva Drugs for Herpes Labialis Oral Herpes Product Overview Table 58. Teva Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Teva Business Overview Table 60. Teva Drugs for Herpes Labialis Oral Herpes SWOT Analysis Table 61. Teva Recent Developments Table 62. Mylan Drugs for Herpes Labialis Oral Herpes Basic Information Table 63. Mylan Drugs for Herpes Labialis Oral Herpes Product Overview Table 64. Mylan Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Mylan Business Overview Table 66. Mylan Drugs for Herpes Labialis Oral Herpes SWOT Analysis Table 67. Mylan Recent Developments Table 68. Cadila Drugs for Herpes Labialis Oral Herpes Basic Information Table 69. Cadila Drugs for Herpes Labialis Oral Herpes Product Overview Table 70. Cadila Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Cadila Business Overview Table 72. Cadila Drugs for Herpes Labialis Oral Herpes SWOT Analysis Table 73. Cadila Recent Developments Table 74. Apotex Drugs for Herpes Labialis Oral Herpes Basic Information Table 75. Apotex Drugs for Herpes Labialis Oral Herpes Product Overview Table 76. Apotex Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Apotex Business Overview Table 78. Apotex Recent Developments Table 79. Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Basic Information Table 80. Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Product Overview Table 81. Daewoong Pharmaceutical Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Daewoong Pharmaceutical Business Overview Table 83. Daewoong Pharmaceutical Recent Developments Table 84. Livzon Drugs for Herpes Labialis Oral Herpes Basic Information Table 85. Livzon Drugs for Herpes Labialis Oral Herpes Product Overview Table 86. Livzon Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Livzon Business Overview Table 88. Livzon Recent Developments Table 89. Luoxin Drugs for Herpes Labialis Oral Herpes Basic Information Table 90. Luoxin Drugs for Herpes Labialis Oral Herpes Product Overview Table 91. Luoxin Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Luoxin Business Overview Table 93. Luoxin Recent Developments Table 94. Med shine Drugs for Herpes Labialis Oral Herpes Basic Information Table 95. Med shine Drugs for Herpes Labialis Oral Herpes Product Overview Table 96. Med shine Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Med shine Business Overview Table 98. Med shine Recent Developments Table 99. Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Basic Information Table 100. Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Product Overview Table 101. Bayer (Campho Phenique) Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Bayer (Campho Phenique) Business Overview Table 103. Bayer (Campho Phenique) Recent Developments Table 104. Blistex Drugs for Herpes Labialis Oral Herpes Basic Information Table 105. Blistex Drugs for Herpes Labialis Oral Herpes Product Overview Table 106. Blistex Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Blistex Business Overview Table 108. Blistex Recent Developments Table 109. Kelun Drugs for Herpes Labialis Oral Herpes Basic Information Table 110. Kelun Drugs for Herpes Labialis Oral Herpes Product Overview Table 111. Kelun Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Kelun Business Overview Table 113. Kelun Recent Developments Table 114. Hikma Drugs for Herpes Labialis Oral Herpes Basic Information Table 115. Hikma Drugs for Herpes Labialis Oral Herpes Product Overview Table 116. Hikma Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Hikma Business Overview Table 118. Hikma Recent Developments Table 119. Haiwang Drugs for Herpes Labialis Oral Herpes Basic Information Table 120. Haiwang Drugs for Herpes Labialis Oral Herpes Product Overview Table 121. Haiwang Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Haiwang Business Overview Table 123. Haiwang Recent Developments Table 124. Carmex Drugs for Herpes Labialis Oral Herpes Basic Information Table 125. Carmex Drugs for Herpes Labialis Oral Herpes Product Overview Table 126. Carmex Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Carmex Business Overview Table 128. Carmex Recent Developments Table 129. Cipher Drugs for Herpes Labialis Oral Herpes Basic Information Table 130. Cipher Drugs for Herpes Labialis Oral Herpes Product Overview Table 131. Cipher Drugs for Herpes Labialis Oral Herpes Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Cipher Business Overview Table 133. Cipher Recent Developments Table 134. Global Drugs for Herpes Labialis Oral Herpes Sales Forecast by Region (K Units) Table 135. Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Region (M USD) Table 136. North America Drugs for Herpes Labialis Oral Herpes Sales Forecast by Country (2022-2028) & (K Units) Table 137. North America Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country (2022-2028) & (M USD) Table 138. Europe Drugs for Herpes Labialis Oral Herpes Sales Forecast by Country (2022-2028) & (K Units) Table 139. Europe Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country (2022-2028) & (M USD) Table 140. Asia Pacific Drugs for Herpes Labialis Oral Herpes Sales Forecast by Region (2022-2028) & (K Units) Table 141. Asia Pacific Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Region (2022-2028) & (M USD) Table 142. South America Drugs for Herpes Labialis Oral Herpes Sales Forecast by Country (2022-2028) & (K Units) Table 143. South America Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country (2022-2028) & (M USD) Table 144. Middle East and Africa Drugs for Herpes Labialis Oral Herpes Consumption Forecast by Country (2022-2028) & (Units) Table 145. Middle East and Africa Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Country (2022-2028) & (M USD) Table 146. Global Drugs for Herpes Labialis Oral Herpes Sales Forecast by Type (2022-2028) & (K Units) Table 147. Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Type (2022-2028) & (M USD) Table 148. Global Drugs for Herpes Labialis Oral Herpes Price Forecast by Type (2022-2028) & (USD/Unit) Table 149. Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) Forecast by Application (2022-2028) Table 150. Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Drugs for Herpes Labialis Oral Herpes Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD), 2017-2028 Figure 5. Global Drugs for Herpes Labialis Oral Herpes Market Size (M USD) (2017-2028) Figure 6. Global Drugs for Herpes Labialis Oral Herpes Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Drugs for Herpes Labialis Oral Herpes Market Size (M USD) by Country (M USD) Figure 11. Drugs for Herpes Labialis Oral Herpes Sales Share by Manufacturers in 2020 Figure 12. Global Drugs for Herpes Labialis Oral Herpes Revenue Share by Manufacturers in 2020 Figure 13. Drugs for Herpes Labialis Oral Herpes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Drugs for Herpes Labialis Oral Herpes Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Drugs for Herpes Labialis Oral Herpes Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Drugs for Herpes Labialis Oral Herpes Market Share by Type Figure 18. Sales Market Share of Drugs for Herpes Labialis Oral Herpes by Type (2017-2022) Figure 19. Sales Market Share of Drugs for Herpes Labialis Oral Herpes by Type in 2021 Figure 20. Market Size Share of Drugs for Herpes Labialis Oral Herpes by Type (2017-2022) Figure 21. Market Size Market Share of Drugs for Herpes Labialis Oral Herpes by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Drugs for Herpes Labialis Oral Herpes Market Share by Application Figure 24. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Application (2017-2022) Figure 25. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Application in 2021 Figure 26. Global Drugs for Herpes Labialis Oral Herpes Market Share by Application (2017-2022) Figure 27. Global Drugs for Herpes Labialis Oral Herpes Market Share by Application in 2020 Figure 28. Global Drugs for Herpes Labialis Oral Herpes Sales Growth Rate by Application (2017-2022) Figure 29. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share by Region (2017-2022) Figure 30. North America Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Drugs for Herpes Labialis Oral Herpes Sales Market Share by Country in 2020 Figure 32. U.S. Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Drugs for Herpes Labialis Oral Herpes Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Drugs for Herpes Labialis Oral Herpes Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Drugs for Herpes Labialis Oral Herpes Sales Market Share by Country in 2020 Figure 37. Germany Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (K Units) Figure 43. Asia Pacific Drugs for Herpes Labialis Oral Herpes Sales Market Share by Region in 2020 Figure 44. China Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (K Units) Figure 50. South America Drugs for Herpes Labialis Oral Herpes Sales Market Share by Country in 2020 Figure 51. Brazil Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Drugs for Herpes Labialis Oral Herpes Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Drugs for Herpes Labialis Oral Herpes Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Drugs for Herpes Labialis Oral Herpes Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Drugs for Herpes Labialis Oral Herpes Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Drugs for Herpes Labialis Oral Herpes Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Drugs for Herpes Labialis Oral Herpes Market Share Forecast by Type (2022-2028) Figure 65. Global Drugs for Herpes Labialis Oral Herpes Sales Forecast by Application (2022-2028) Figure 66. Global Drugs for Herpes Labialis Oral Herpes Market Share Forecast by Application (2022-2028)

•GSK •Novartis •Teva •Mylan •Cadila •Apotex •Daewoong Pharmaceutical •Livzon •Luoxin •Med shine •Bayer (Campho Phenique) •Blistex •Kelun •Hikma •Haiwang •Carmex •Cipher